Albany Molecular Research PEG Ratio

The latest PEG ratio for AMRI is 25.42. That is above the sector sector average of -7.59. Investors often review this figure alongside Albany Molecular Research's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, AMRI currently prints 25.42 for PEG ratio, while the sector average sits near -7.59. That is roughly 434.9% above the sector mean. Large gaps often invite a closer look at Albany Molecular Research's growth, margins, and balance sheet.

A PEG ratio of 25.42 for Albany Molecular Research is not 'good' or 'bad' on its own. Compare it with the peer average (-7.59) and with AMRI's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting AMRI's PEG ratio (25.42), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.